| Premier Dentistry | |
|
9200 Highway 119 Suite 200 Alabaster AL 35007-5337 | |
| (205) 621-5304 | |
| (205) 621-5306 |
| Full Name | Premier Dentistry |
|---|---|
| Speciality | Dentist |
| Location | 9200 Highway 119, Alabaster, Alabama |
| Authorized Official Name and Position | Becky Presley (MANAGER) |
| Authorized Official Contact | 2058713523 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Premier Dentistry 9200 Highway 119 Suite 200 Alabaster AL 35007-5337 Ph: (205) 621-5304 | Premier Dentistry 9200 Highway 119 Suite 200 Alabaster AL 35007-5337 Ph: (205) 621-5304 |
| NPI Number | 1710172168 |
|---|---|
| Provider Enumeration Date | 09/10/2007 |
| Last Update Date | 09/10/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710172168 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 5130 (Alabama) | Primary |
News Archive
Tetraphase Pharmaceuticals, Inc., today announced that 12 poster presentations and an oral summary presentation on preclinical and clinical data for its lead drug candidate, TP-434, will be presented at the 2010 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA, being held September 12 -15 at the Boston Convention and Exhibition Center.
Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine.
Winston Pharmaceuticals, Inc.,, announced that the National Institutes of Health has awarded Winston a grant under the Small Business Innovation Research program supporting the development of Civamide, a proprietary TRPV-1 receptor modulator, for the treatment of postherpetic neuralgia of the trigeminal nerve.
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals (Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to develop and commercialize Santhera's JP-1730/fipamezole for the treatment of Dyskinesia in Parkinson's Disease (DPD). JP-1730/ fipamezole is a first-in-class compound that, in a recent Phase IIb study, displayed the potential to reduce levodopa-induced dyskinesia.
› Verified 1 days ago
Alabama Sleep Solutions Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 122 7th Ave Ne, Alabaster, AL 35007 Phone: 205-663-6545 | |
Albritton & Ardovino Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 Colonial Promenade Pkwy, Suite 400, Alabaster, AL 35007 Phone: 205-664-7610 | |
Callyn Tedin Dmd Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 129 1st St N, Alabaster, AL 35007 Phone: 205-663-3612 Fax: 205-663-6446 | |
Koslin & Kahn, P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 227b 1st St N, Alabaster, AL 35007 Phone: 205-663-9969 Fax: 205-663-9949 | |
Stonecreek Dental Care - Alabaster Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1130 1st Street N, Alabaster, AL 35007 Phone: 205-663-1280 Fax: 205-663-5565 | |
Everts, Livingston And Miller Surgical Services, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 420 1st St N, Alabaster, AL 35007 Phone: 205-208-0167 | |
Premier Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 9200 Highway 119, Suite 200, Alabaster, AL 35007 Phone: 205-621-5304 Fax: 205-621-5306 |